Nicholas Donoghoe sold $8.2M of AbbVie (ABBV)

Executed Aug 14, disclosed Aug 18, 4 days later.

Value, as filed

$8.2M

32,710 sh × $250.00

Executed

Aug 14

the trade date, as filed

Disclosed

Aug 18

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ND Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER profile →

Nicholas Donoghoe (EVP, CHIEF BUS/STRAT OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $8.2M of ABBV (32,710 sh × $250.00, as filed), executed Aug 14.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Nicholas Donoghoe in ABBV

ABBVSALE AbbVie Inc. $2.6M
13,295 sh across 2 lots
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET